Child born after mother given ovary from twin in world first

Apr 17, 2011

A woman suffering a chromosome disorder has given birth to a healthy daughter thanks to an ovarian transplant from her sister in a world first, doctors said Saturday.

The baby, named Victoria, was born in the Paris region on March 8, and is free of the disorder known as which affects both her mother and her aunt.

Karine Thiriot, 39, said she had been trying to conceive, notably through in vitro , for some 15 years.

"It was the first such transplant in the world between twins with Turner syndrome,", Belgian gynaecologist Jacques Donnez, who carried out the operation in August 2009, told AFP.

It was also the first ovarian transplant to be done in Europe, said Donnez, who has since successfully performed a similar operation involving sisters who are not .

Thiriot lacked ovaries because of Turner Syndrome, which affects one girl born in 2,500, but her twin sister, though having a similar chromosome deficiency, was fertile and had two children before the transplant.

A few months after the transplant Thiriot's regular had established itself and she became pregnant quite normally.

"Victoria is totally normal and doen't have Turner syndrome," she said.

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Double identities lie behind chromosome disorders

Jul 08, 2007

Chromosome disorders in sex cells cause infertility, miscarriage and irregular numbers of chromosomes (aneuploidy) in neonates. A new study from Karolinska Institutet published in the scientific journal Nature Genetics shows ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Man among first in US to get 'bionic eye' (Update)

A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure ...